EX-229

CAS No. 1219739-36-2

EX-229 ( EX 229;EX229 )

Catalog No. M10829 CAS No. 1219739-36-2

A small molecule AMPK activator that dose-dependently increases AMPK activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 Get Quote
5MG 61 Get Quote
10MG 102 Get Quote
25MG 210 Get Quote
50MG 356 Get Quote
100MG 536 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EX-229
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule AMPK activator that dose-dependently increases AMPK activity.
  • Description
    A small molecule AMPK activator that dose-dependently increases AMPK activity of α1-, α2-, β1- and β2-containing complexes at 50 uM; induces AMPK activation and glucose uptak in a wortmannin-independent manner; increases fatty acid oxidation in L6 myotubes.
  • Synonyms
    EX 229;EX229
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    AMPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1219739-36-2
  • Formula Weight
    431.88
  • Molecular Formula
    C24H18ClN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 5.4 mg/mL12.50 mM
  • SMILES
    O=C(O)C1=CC(OC2=NC3=CC(C4=CC5=C(N(C)C=C5)C=C4)=C(Cl)C=C3N2)=CC=C1C
  • Chemical Name
    5-{[6-chloro-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl]oxy}-2-methyl-benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lai YC, et al. Biochem J. 2014 Jun 15;460(3):363-75.
2. Bultot L, et al. Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E706-E719.
3. Patent WO2010036613, EX229.
molnova catalog
related products
  • Metformin hydrochlor...

    Metformin Hcl, a widely used anti-diabetic drug has potential efficacy as an anti-Y drug.

  • Gomisin J

    Gomisin J is a natural product and have vasodilatory activity.?Gomisin J suppresses lipid accumulation by regulating the expression of lipogenic and lipolytic enzymes and inflammatory molecules through activation of AMPK, LKB1 and Ca2+/calmodulin-dependent protein kinase II and inhibition of fetuin-A in HepG2 cells.

  • PF-06409577

    PF-06409577(PF06409577, PF 6409577)is a potent, selective AMPK β1-containing isoforms activator with TR-FRET EC50 of 7.0 and 6.8 nM for α1β1γ1 and α2β1γ1, respectively.